Skip to main content
Article
Immunoscore and Immunoprofiling in cancer: an update from the melanoma and immunotherapy bridge 2015
Journal of Translational Medicine (2016)
  • J Galon, Paris Descartes University
  • J Galon, French Institute of Health and Medical Research
  • B A Fox, Oregon Health & Science University
  • B A Fox, Providence Portland Medical Center
  • C B Bifulco, Providence Portland Medical Center
  • G Masucci, Department of Oncology-Pathology, The Karolinska Hospital, Stockholm, Sweden
  • Tilman Rau, University of Bern
  • G Botti, Unit of Pathology, IRCCS, Istituto Nazionale Tumori, Fondazione “G. Pascale”, Naples, Italy
  • F M Marincola, Qatar Airways
  • G Ciliberto, IRCCS, Istituto Nazionale Tumori, Fondazione “G. Pascale”,Scentific Directorate, Naples, Italy
  • F Pages, University Paris Descartes, Paris, France
  • P A Ascierto, Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy, Istituto Nazionale Tumori, Fondazione “G. Pascale”, Naples, Italy
  • M Capone, Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy, Istituto Nazionale Tumori, Fondazione “G. Pascale”, Naples, Italy
Publication Date
September 20, 2016
DOI
10.1186/S12967-016-1029-Z
Citation Information
J Galon, J Galon, B A Fox, B A Fox, et al.. "Immunoscore and Immunoprofiling in cancer: an update from the melanoma and immunotherapy bridge 2015" Journal of Translational Medicine Vol. 14 Iss. 1 (2016) p. 273
Available at: http://works.bepress.com/carlo-bifulco/85/